Mini Mikkipedia - When GLP-1 Weight Loss Dims Motivation
About this episode
This episode discusses the impact of high-dose tirzepatide on motivation and the experience of anhedonia in weight loss patients.
This episode explores emerging evidence that high-dose tirzepatide may reduce more than appetite and food noise in some people. Mikki breaks down a new case series involving three women who experienced anhedonia, a loss of motivation or interest in previously rewarding activities, despite achieving substantial weight loss. She explains the difference between “wanting” and “liking,” how GLP-1 medications may influence dopamine reward pathways, and why symptoms can feel different from depression or early medication side effects. The cases suggest that dose reduction may restore motivation without necessarily compromising weight-loss maintenance. While three cases cannot establish causation or prevalence, the findings highlight the importance of monitoring exercise, hobbies, social engagement, and overall enjoyment alongside weight, appetite, and gastrointestinal symptoms. Topics Covered What anhedonia is and how it differs from depression Three cases involving high-dose tirzepatide The potential role of dopamine and reward pathways Why dose reduction improved symptoms in these cases Practical considerations for patients and prescribers Contact Mikki: https://mikkiwilliden.com/…
Sponsors
Calocurb, Nuzest
More episodes of Mikkipedia
- HRT, Tirzepatide and Weight Loss After Menopause with Professor Daniela Hurtado and Dr Regina Castaneda
- Fueled or Fooled? Rethinking Ultra-High Carbohydrate Fuelling with Dr Dan Plews
- Mini Mikkipedia - Why Diets Fall Apart After Week Three
- Brandon Da Cruz - The Truth About Body Recomposition
- Mini Mikkipedia - Lipoedema: When Fat Loss Isn’t the Issue
- Choose Your Hard: Grant Schofield on Human Potential
Explore listener stats, chart rankings, contacts and more on the Mikkipedia podcast page.